U.S. federal trademark · Serial No. 90981524 · Reg. No. 8042862
pharmaceutical research and development in the field of cancer, carcinomas, sarcomas, myelomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders; medical, pharmaceutical, and scientific research in the field of cancer, carcinomas, sarcomas, myelomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders; medical, pharmaceutical, and scientific research in the field of biomarkers for use in diagnosing, preventing, and treating diseases and disorders, namely cancer, carcinomas, sarcomas, myelomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders; clinical research and testing services not for medical diagnostic purposes in the field of cancer, carcinomas, sarcomas, myelomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals and clinical trials for use in diagnosing, preventing, and treating diseases and disorders, namely cancer, carcinomas, sarcomas, myelomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders
pharmaceutical products, namely, preparations for the prevention and treatment of cancer, lymphomas
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.